Skip to main content
CGEN
NASDAQ Life Sciences

Compugen Q3 Loss Narrower Than Expected; Revenue More Than Doubles

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.99
Mkt Cap
$188.509M
52W Low
$1.43
52W High
$3.235
52W Position info
39% above low
Off High info
38% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

CGEN sits 39% above its 52-week low of $1.43 on light trading volume (0.1× avg).

Summary

Compugen posted a Q3 adjusted loss of 6 cents a share, better than the 8-cent loss five analysts expected, and revenue of $3.82 million versus a $1.70 million consensus — up 102.1% from a year ago. The quarter's net loss was $5.8 million. The company ended with $117.5 million in cash, which it says funds operations into 2029, so there is no near-term financing pressure despite the ongoing losses. The stock is down 17.6% this quarter but up 28.1% year to date, and the average analyst rating is 'strong buy' with a median 12-month price target of $4.00 versus a $1.96 last close. The revenue beat against a small consensus base is the number that matters here — it shows the collaboration revenue line is running ahead of expectations.

At the time of this announcement, CGEN was trading at $1.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $188.5M. The 52-week trading range was $1.43 to $3.24. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CGEN - Latest Insights

CGEN
May 18, 2026, 4:02 PM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $2.86
Real-time Price: $2.13 info
Change: -$0.730 (-26%) info
Market Cap: $201.77M info
CGEN
Mar 02, 2026, 7:16 AM EST
Filing Type: 20-F
Importance Score:
9
Price at Filing: $1.88
Real-time Price: $2.13 info
Change: +$0.250 (+13%) info
Market Cap: $201.77M info
CGEN
Mar 02, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.81
Real-time Price: $2.13 info
Change: +$0.320 (+18%) info
Market Cap: $201.77M info